Neuromedin S vs Neuropeptide S — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuromedin S (NMS) is a 36-amino acid amidated neuropeptide discovered in 2005 that shares a C-terminal amino acid sequence with neuromedin U (NMU) and activates the same NMUR1 and NMUR2 receptors. However, NMS has a markedly different expression pattern: while NMU is broadly exp...
Calculate Neuromedin S dose →Neuropeptide S (NPS) is a 20-amino acid peptide discovered in 2004 that acts on the NPS receptor (NPSR1), a Gq/Gs-coupled GPCR with highest expression in amygdala, hypothalamus, and brainstem arousal centers. NPS produces a distinctive combination of simultaneous wakefulness prom...
Calculate Neuropeptide S dose →| Parameter | Neuromedin S | Neuropeptide S |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Preclinical |
| Half-Life | Short (minutes, estimated) | Short (minutes, CNS) |
| Typical Dose | 1-10 nmol (central, animal) | 0.1-10 nmol (ICV, animal) |
| Frequency | Variable | Variable |
| Route | Intracerebroventricular, Subcutaneous | Intracerebroventricular (animal research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.